Potentiated Vaccine

for Global Immunization

Company motto

Potentiates vaccine for global immunization
No child left alone without vaccine

Vision statement

Innovative technology for novel vaccine
Cold chain free nasal vaccine
Peptide vaccine without pathogen
Low cost T-Cell therapy for cancer and infectious disease

What NA Vaccine Institute has

An adjuvant for potentiated vaccine
An adjuvant for both parenteral and mucosal vaccination
An adjuvant with a potent cell mediated immunity for cancer vaccines
The cost effective production system for the adjuvant
Produces 100K dose of the adjuvant in less than a month

What NA Vaccine Institute does

Adjuvant related business;

Licensing out of the vaccine adjuvant and/or contract research for the adjuvant development

Development of adjuvant for more potentiated but safer vaccines
Development for adjuvant for more effective parentreal and mucosal vaccine
Development for adjuvant for oral or nasal vaccine

Vaccine development;

Own internal programs and collaboration with others

Nasal flu vaccine with a broad spectrum protection
Nasal vaccine without a medical staff
Vaccine without cold chain
Peptide based vaccine
Neoantigenic cancer vaccine

Where NA Vaccine Institute is heading to

Development of novel adjuvant and enhanced vaccine for global immunization with lower cost and risk.
Vaccines with the breakthrough features of the broad spectrum specificity by intradermal, oral, or nasal delivery routes.
Vaccines with reduce cost and improve efficacy without cold chain
Peptide vaccines without pathogen
Setting up the industrial standard for the production of the novel adjuvant molecule, the industrial scale production, and QC guide line for each production steps.